We offer a range of coronavirus bioreagents for research and development.
Our range of products includes:
Monoclonal and polyclonal antibodies
ACE2, nucleocapsid and spike peptides and peptide libraries
SARS-CoV-2 virus-like particles (VLP) that encapsulate an alphavirus-derived RNA genome for rapid report expression (GFP, RFP or luciferase) in target cells. VLPs are assembled with all 4 structural proteins (S, M, N, and E) of SARS-CoV-2.
